Xeltis data shortlisted at EACTS Techno-College Innovation Award

2019-02-14T11:30:53+01:00October 19th, 2018|News|

An abstract on Xeltis clinical data has been shortlisted as one of five finalists at the EACTS Techno-College Innovation Award. Professor Tomasz Mroczek from the Children’s University Hospital, Krakow, Poland will present 1-year Xeltis data on the “First clinical experience [...]

Xeltis’ aortic valve one of highest peer-review oral abstracts at TCT

2019-02-14T11:33:48+01:00September 18th, 2018|News|

Initial in vivo experience on Xeltis’ restorative aortic valve will feature as one of the highest peer-reviewed oral abstracts of TCT 2018. Professor Christian Spaulding, Chief, Interventional Cardiology, European Hospital Georges Pompidou, Paris (F), will present long-term pre-clinical on Xeltis’ [...]

Xeltis’ restorative technology featured at ISACB

2019-02-14T11:34:45+01:00September 14th, 2018|News|

Preclinical data on Xeltis’ restorative heart valve technology will feature at the 16th International Society of Applied Cardiovascular Biology (ISACB) Biennial meeting. Professor Frederick J. Schoen from Harvard Medical School will present 1-year preclinical data outlining the capability of Xeltis [...]

The Children’s Hospital Colorado joins the Xplore-2 trial

2019-02-14T11:35:40+01:00July 5th, 2018|News|

The Children’s Hospital Colorado has joined other prominent U.S. pediatric centers in the Xplore-2 clinical research study, the first medical center in the Mountain States to take part in the trial. The medical institutions already enrolling patients as part of the [...]

Xeltis restorative technology for aortic valves at ISMICS

2018-06-13T09:55:09+01:00June 13th, 2018|News|

The potential for Xeltis’ restorative technology in aortic valves will be showcased at the International Society for Minimally Invasive Cardiothoracic Surgery meeting in Vancouver on June 13-16.    Doctor Gregory Fontana, CardioVascular Institute Los Robles Hospital, Thousand Oaks, California, will [...]

Xeltis’ restorative aortic valves at HVS

2018-04-06T10:00:44+01:00April 6th, 2018|News|

Dr Gregory Fontana, National Medical Director for Cardiovascular Research, at the Hospital Corporation of America, Nashville, Tennessee, (U.S.), will present data on Xeltis’ restorative aortic valves at the Heart Valve Society meeting in New York on April 12-14, 2018. In [...]

Positive progression of ETR clinical trials at WCPCCS

2017-07-20T09:00:21+01:00July 20th, 2017|News|

Positive Xeltis data from two clinical trials on Endogenous Tissue Restoration (ETR) applications show encouraging progression for the RestoreX technology. The data have been shared at the 7th World Congress of Pediatric Cardiology & Cardiac Surgery (WCPCCS) in Barcelona, Spain. [...]

Xeltis awarded extended ISO certification

2016-07-08T12:19:24+01:00July 8th, 2016|News|

Xeltis’ Eindhoven facilities have been recognized as complying with the requirements of ISO 13485:2003 and EN ISO 13485:2012 for the design, development and manufacture of sterile bioabsorbable cardiovascular implants. The extended certification demonstrates Xeltis’ commitment to upholding the vigorous manufacturing [...]

Go to Top